Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
:RHT
RESEARCH TOOLSreports
RHT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.09
Previous CloseN/A
Volume166.47K
Average Volume (3M)427.11K
Market Cap
AU$17.01M
Enterprise ValueAU$24.31M
Total Cash (Recent Filing)AU$2.14M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)140.0
Beta1.00
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding459,616,150
10 Day Avg. Volume177,557
30 Day Avg. Volume427,109
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Resonance Health Ltd News
PremiumCompany Announcements
Resonance Health Ltd Reports Robust Financial Growth in 1H FY25
PremiumCompany Announcements
Resonance Health Reports Revenue Growth but Increased Losses in H1 2024
PremiumCompany Announcements
Resonance Health to Announce Half-Year Results and Host Conference Call
PremiumCompany Announcements
Resonance Health Boosts Cash Reserves with R&D Tax Refund
PremiumCompany Announcements
Resonance Health Unveils Innovative Imaging Tech on Roadshow
PremiumCompany Announcements
Resonance Health Ltd Secures Strong Shareholder Support---
Options Prices
Currently, No data available
---
Ownership Overview
17.01% Insiders
―
Mutual Funds
― Other Institutional Investors
82.99% Public Companies and
Individual Investors
RHT FAQ
What was Resonance Health Ltd’s price range in the past 12 months?
Resonance Health Ltd lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
What is Resonance Health Ltd’s market cap?
Resonance Health Ltd’s market cap is AU$17.01M.
When is Resonance Health Ltd’s upcoming earnings report date?
Resonance Health Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 141 days.
How were Resonance Health Ltd’s earnings last quarter?
Resonance Health Ltd released its earnings results on Feb 27, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Resonance Health Ltd overvalued?
According to Wall Street analysts Resonance Health Ltd’s price is currently Overvalued.
Does Resonance Health Ltd pay dividends?
Resonance Health Ltd does not currently pay dividends.
What is Resonance Health Ltd’s EPS estimate?
Resonance Health Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resonance Health Ltd have?
Resonance Health Ltd has 459,616,150 shares outstanding.
What happened to Resonance Health Ltd’s price movement after its last earnings report?
Resonance Health Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Resonance Health Ltd?
Currently, no hedge funds are holding shares in AU:RHT
---
Resonance Health Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RHT Sentiment 70%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.38%
12-Months-Change
Fundamentals
Return on Equity
-3.11%
Trailing 12-Months
Asset Growth
64.26%
Trailing 12-Months
Company Description
Resonance Health Ltd
Resonance Health Ltd (RHT) is a healthcare technology company specializing in the development and commercialization of innovative medical imaging software and services. Operating primarily in the medical diagnostics sector, the company is renowned for its flagship product, FerriScan, a non-invasive liver diagnostic technology. Resonance Health's solutions are designed to improve patient outcomes by providing accurate and reliable diagnostic tools that assist in the management of diseases such as iron overload disorders.
---
Technical Analysis
---